Long-Term Outcome of a Prospective Randomized Trial Comparing Continuous Lenalidomide/Dexamethasone with Lenalidomide/Dexamethasone Induction, MEL140 with Autologous Blood Stem Cell Transplantation and Single Agent Lenalidomide Maintenance in Patients of Age 60-75 Years with Newly Diagnosed Multiple
暂无分享,去创建一个
H. Einsele | T. Brümmendorf | F. Bassermann | A. Hinke | T. Decker | C. Straka | R. Naumann | C. Langer | M. Gramatzki | B. Hertenstein | B. Metzner | N. Frickhofen | J. Reusch | T. Kubin | C. Gerecke | A. Reichle | M. Engelhardt | S. Knop | B. Schmidt | H. Hebart | H. Salwender | T. Dechow | W. Jung | M. Grube | W. Roesler | J. Krönke | M. Kaufmann | S. Fuhrmann | G. Schilling | P. Bojko | J. Greiner | I. Metzler | M. Kull | Aneta Schieferdecker | C. Schmidt | Kerstin Schaefer-Eckart | Juliana Ababei | M. Hentrich | Elisabeth Fritz